{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T17:48:40Z","timestamp":1743097720352,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":35,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071644010"},{"type":"electronic","value":"9781071644027"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4402-7_2","type":"book-chapter","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T12:46:02Z","timestamp":1741005962000},"page":"13-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metastatic Melanoma Treatment and Prophylaxis with S100A9-Targeting Cowpea Mosaic Virus Nanoparticles"],"prefix":"10.1007","author":[{"given":"Young Hun","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole F.","family":"Steinmetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.tips.2013.03.001","volume":"34","author":"A Wells","year":"2013","unstructured":"Wells A, Grahovac J, Wheeler S, Ma B, Lauffenburger D (2013) Targeting tumor cell motility as a strategy against invasion and metastasis. Trends Pharmacol Sci 34:283\u2013289. https:\/\/doi.org\/10.1016\/j.tips.2013.03.001","journal-title":"Trends Pharmacol Sci"},{"key":"2_CR2","first-page":"519M","volume":"88","author":"O Peart","year":"2017","unstructured":"Peart O (2017) Metastatic breast cancer. Radiol Technol 88:519M\u2013539M","journal-title":"Radiol Technol"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000456014","volume":"40","author":"L Enewold","year":"2017","unstructured":"Enewold L, Sharon E, Harlan LC (2017) Metastatic melanoma: treatment and survival in the US after the introduction of ipilimumab and vemurafenib. Oncol Res Treat 40:174\u2013183. https:\/\/doi.org\/10.1159\/000456014","journal-title":"Oncol Res Treat"},{"key":"2_CR4","first-page":"770","volume":"11","author":"S Zhang","year":"2005","unstructured":"Zhang S, Wang Y, Ding Y, Wu Y (2005) Long term survival results in advanced prostate cancer treated with combined androgen blockade. Zhonghua Nan Ke Xue 11:770\u2013771, 774","journal-title":"Zhonghua Nan Ke Xue"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","volume":"5","author":"X Guan","year":"2015","unstructured":"Guan X (2015) Cancer metastases: challenges and opportunities. Acta Pharm Sin B 5:402\u2013418. https:\/\/doi.org\/10.1016\/j.apsb.2015.07.005","journal-title":"Acta Pharm Sin B"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jjco\/hyaa268","volume":"51","author":"H Sato","year":"2021","unstructured":"Sato H, Demaria S, Ohno T (2021) The role of radiotherapy in the age of immunotherapy. Jpn J Clin Oncol 51:513\u2013522. https:\/\/doi.org\/10.1093\/jjco\/hyaa268","journal-title":"Jpn J Clin Oncol"},{"doi-asserted-by":"crossref","unstructured":"Siamof CM, Goel S, Cai W (2020) Moving beyond the pillars of cancer treatment: perspectives from nanotechnology. Front Chem 8. https:\/\/www.frontiersin.org\/article\/10.3389\/fchem.2020.598100. Accessed 17 May 2022","key":"2_CR7","DOI":"10.3389\/fchem.2020.598100"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13045-019-0746-1","volume":"12","author":"H Wang","year":"2019","unstructured":"Wang H, Kaur G, Sankin AI, Chen F, Guan F, Zang X (2019) Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies. J Hematol Oncol 12:59. https:\/\/doi.org\/10.1186\/s13045-019-0746-1","journal-title":"J Hematol Oncol"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3390\/cancers12071826","volume":"12","author":"E Alard","year":"2020","unstructured":"Alard E, Butnariu A-B, Grillo M, Kirkham C, Zinovkin DA, Newnham L, Macciochi J, Pranjol MZI (2020) Advances in anti-cancer immunotherapy: car-T cell, checkpoint inhibitors, dendritic cell vaccines, and oncolytic viruses, and emerging cellular and molecular targets. Cancers (Basel) 12:1826. https:\/\/doi.org\/10.3390\/cancers12071826","journal-title":"Cancers (Basel)"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.14740\/jocmr3750","volume":"11","author":"R Bajwa","year":"2019","unstructured":"Bajwa R, Cheema A, Khan T, Amirpour A, Paul A, Chaughtai S, Patel S, Patel T, Bramson J, Gupta V, Levitt M, Asif A, Hossain MA (2019) Adverse effects of immune checkpoint inhibitors (programmed death-1 inhibitors and cytotoxic T-lymphocyte-associated protein-4 inhibitors): results of a retrospective study. J Clin Med Res 11:225\u2013236. https:\/\/doi.org\/10.14740\/jocmr3750","journal-title":"J Clin Med Res"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.1002\/cam4.1722","volume":"7","author":"J Duan","year":"2018","unstructured":"Duan J, Wang Y, Jiao S (2018) Checkpoint blockade-based immunotherapy in the context of tumor microenvironment: opportunities and challenges. Cancer Med 7:4517\u20134529. https:\/\/doi.org\/10.1002\/cam4.1722","journal-title":"Cancer Med"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1080\/07853890802698842","volume":"41","author":"H Samaranayake","year":"2009","unstructured":"Samaranayake H, Wirth T, Schenkwein D, R\u00e4ty JK, Yl\u00e4-Herttuala S (2009) Challenges in monoclonal antibody-based therapies. Ann Med 41:322\u2013331. https:\/\/doi.org\/10.1080\/07853890802698842","journal-title":"Ann Med"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-021-00459-7","volume":"11","author":"RC Sterner","year":"2021","unstructured":"Sterner RC, Sterner RM (2021) CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J 11:1\u201311. https:\/\/doi.org\/10.1038\/s41408-021-00459-7","journal-title":"Blood Cancer J"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40257-016-0238-9","volume":"18","author":"PK Bommareddy","year":"2017","unstructured":"Bommareddy PK, Patel A, Hossain S, Kaufman HL (2017) Talimogene laherparepvec (T-VEC) and other oncolytic viruses for the treatment of melanoma. Am J Clin Dermatol 18:1\u201315. https:\/\/doi.org\/10.1007\/s40257-016-0238-9","journal-title":"Am J Clin Dermatol"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/cancers11040515","volume":"11","author":"A Kerstetter-Fogle","year":"2019","unstructured":"Kerstetter-Fogle A, Shukla S, Wang C, Beiss V, Harris PLR, Sloan AE, Steinmetz NF (2019) Plant virus-like particle in situ vaccine for intracranial glioma immunotherapy. Cancers (Basel) 11:515. https:\/\/doi.org\/10.3390\/cancers11040515","journal-title":"Cancers (Basel)"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1021\/acs.molpharmaceut.8b00316","volume":"15","author":"AA Murray","year":"2018","unstructured":"Murray AA, Wang C, Fiering S, Steinmetz NF (2018) In situ vaccination with cowpea vs tobacco mosaic virus against melanoma. Mol Pharm 15:3700\u20133716. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00316","journal-title":"Mol Pharm"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"2002299","DOI":"10.1002\/adfm.202002299","volume":"30","author":"C Wang","year":"2020","unstructured":"Wang C, Steinmetz NF (2020) A combination of cowpea mosaic virus and immune checkpoint therapy synergistically improves therapeutic efficacy in three tumor models. Adv Funct Mater 30:2002299. https:\/\/doi.org\/10.1002\/adfm.202002299","journal-title":"Adv Funct Mater"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nnano.2015.292","volume":"11","author":"PH Lizotte","year":"2016","unstructured":"Lizotte PH, Wen AM, Sheen MR, Fields J, Rojanasopondist P, Steinmetz NF, Fiering S (2016) In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer. Nat Nanotechnol 11:295\u2013303. https:\/\/doi.org\/10.1038\/nnano.2015.292","journal-title":"Nat Nanotechnol"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1021\/acs.molpharmaceut.8b00126","volume":"15","author":"PJ Hoopes","year":"2018","unstructured":"Hoopes PJ, Wagner RJ, Duval K, Kang K, Gladstone DJ, Moodie KL, Crary-Burney M, Ariaspulido H, Veliz FA, Steinmetz NF, Fiering SN (2018) Treatment of canine oral melanoma with nanotechnology-based immunotherapy and radiation. Mol Pharm 15:3717\u20133722. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00126","journal-title":"Mol Pharm"},{"key":"2_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004044","volume":"10","author":"D Alonso-Miguel","year":"2022","unstructured":"Alonso-Miguel D, Valdivia G, Guerrera D, Perez-Alenza MD, Pantelyushin S, Alonso-Diez A, Beiss V, Fiering S, Steinmetz NF, Suarez-Redondo M, vom Berg J, Pe\u00f1a L, Arias-Pulido H (2022) Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer. J Immunother Cancer 10:e004044. https:\/\/doi.org\/10.1136\/jitc-2021-004044","journal-title":"J Immunother Cancer"},{"key":"2_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120914","volume":"275","author":"C Mao","year":"2021","unstructured":"Mao C, Beiss V, Fields J, Steinmetz NF, Fiering S (2021) Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors. Biomaterials 275:120914. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120914","journal-title":"Biomaterials"},{"doi-asserted-by":"publisher","unstructured":"Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J (2018) S100A8\/A9 in inflammation. Front Immunol 9. https:\/\/doi.org\/10.3389\/fimmu.2018.01298. https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01298. Accessed 17 May 2022","key":"2_CR22","DOI":"10.3389\/fimmu.2018.01298"},{"key":"2_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/296149","volume":"2015","author":"MR Tardif","year":"2015","unstructured":"Tardif MR, Chapeton-Montes JA, Posvandzic A, Pag\u00e9 N, Gilbert C, Tessier PA (2015) Secretion of S100A8, S100A9, and S100A12 by neutrophils involves reactive oxygen species and potassium efflux. J Immunol Res 2015:296149. https:\/\/doi.org\/10.1155\/2015\/296149","journal-title":"J Immunol Res"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/ncb1507","volume":"8","author":"S Hiratsuka","year":"2006","unstructured":"Hiratsuka S, Watanabe A, Aburatani H, Maru Y (2006) Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8:1369\u20131375. https:\/\/doi.org\/10.1038\/ncb1507","journal-title":"Nat Cell Biol"},{"doi-asserted-by":"crossref","unstructured":"Huang M, Wu R, Chen L, Peng Q, Li S, Zhang Y, Zhou L, Duan L (2019) S100A9 regulates MDSCs-mediated immune suppression via the RAGE and TLR4 signaling pathways in colorectal carcinoma. Front Immunol 10. https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02243. Accessed 28 Apr 2022","key":"2_CR25","DOI":"10.3389\/fimmu.2019.02243"},{"key":"2_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034207","volume":"7","author":"E K\u00e4llberg","year":"2012","unstructured":"K\u00e4llberg E, Vogl T, Liberg D, Olsson A, Bj\u00f6rk P, Wikstr\u00f6m P, Bergh A, Roth J, Ivars F, Leanderson T (2012) S100A9 interaction with TLR4 promotes tumor growth. PLoS One 7:e34207. https:\/\/doi.org\/10.1371\/journal.pone.0034207","journal-title":"PLoS One"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"28401","DOI":"10.18632\/oncotarget.4951","volume":"6","author":"W-Y Fang","year":"2015","unstructured":"Fang W-Y, Chen Y-W, Hsiao J-R, Liu C-S, Kuo Y-Z, Wang Y-C, Chang K-C, Tsai S-T, Chang M-Z, Lin S-H, Wu L-W (2015) Elevated S100A9 expression in tumor stroma functions as an early recurrence marker for early-stage oral cancer patients through increased tumor cell invasion, angiogenesis, macrophage recruitment and interleukin-6 production. Oncotarget 6:28401\u201328424","journal-title":"Oncotarget"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s13258-019-00856-0","volume":"41","author":"S-H Hwang","year":"2019","unstructured":"Hwang S-H, Ahn J-H, Lee M (2019) Upregulation of S100A9 contributes to the acquired resistance to BRAF inhibitors. Genes Genomics 41:1273\u20131280. https:\/\/doi.org\/10.1007\/s13258-019-00856-0","journal-title":"Genes Genomics"},{"key":"2_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nm.3560","volume":"20","author":"H Qin","year":"2014","unstructured":"Qin H, Lerman B, Sakamaki I, Wei G, Cha S, Rao SS, Qian J, Hailemichael Y, Nurieva R, Dwyer KC, Roth J, Yi Q, Overwijk WW, Kwak LW (2014) Generation of a novel therapeutic peptide that depletes MDSC in tumor-bearing mice. Nat Med 20:676\u2013681. https:\/\/doi.org\/10.1038\/nm.3560","journal-title":"Nat Med"},{"key":"2_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-1-4939-9516-5_10","volume":"2019","author":"AA Murray","year":"2000","unstructured":"Murray AA, Sheen MR, Veliz FA, Fiering SN, Steinmetz NF (2000) In situ vaccination of tumors using plant viral nanoparticles. Methods Mol Biol 2019:111\u2013124. https:\/\/doi.org\/10.1007\/978-1-4939-9516-5_10","journal-title":"Methods Mol Biol"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/nprot.2010.103","volume":"5","author":"HS Leong","year":"2010","unstructured":"Leong HS, Steinmetz NF, Ablack A, Destito G, Zijlstra A, Stuhlmann H, Manchester M, Lewis JD (2010) Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles. Nat Protoc 5:1406\u20131417. https:\/\/doi.org\/10.1038\/nprot.2010.103","journal-title":"Nat Protoc"},{"issue":"21","key":"2_CR32","doi-asserted-by":"publisher","first-page":"2101796","DOI":"10.1002\/advs.202101796","volume":"8","author":"YH Chung","year":"2021","unstructured":"Chung YH, Park J, Cai H, Steinmetz NF (2021) S100A9-targeted cowpea mosaic virus as a prophylactic and therapeutic immunotherapy against metastatic breast cancer and melanoma. Adv Sci 8(21):2101796. https:\/\/doi.org\/10.1002\/advs.202101796","journal-title":"Adv Sci"},{"key":"2_CR33","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1039\/C8TB02276C","volume":"7","author":"J Park","year":"2019","unstructured":"Park J, Gao H, Wang Y, Hu H, Simon DI, Steinmetz NF (2019) S100A9-targeted tobacco mosaic virus nanoparticles exhibit high specificity toward atherosclerotic lesions in ApoE \u2212\/\u2212 mice. J Mater Chem B 7:1842\u20131846. https:\/\/doi.org\/10.1039\/C8TB02276C","journal-title":"J Mater Chem B"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/B978-012374410-4.00562-8","volume-title":"Encyclopedia of virology","author":"GP Lomonossoff","year":"2008","unstructured":"Lomonossoff GP (2008) Cowpea mosaic virus. In: Encyclopedia of virology, pp 569\u2013574. https:\/\/doi.org\/10.1016\/B978-012374410-4.00562-8"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.chembiol.2004.04.011","volume":"11","author":"A Chatterji","year":"2004","unstructured":"Chatterji A, Ochoa WF, Paine M, Ratna BR, Johnson JE, Lin T (2004) New addresses on an addressable virus nanoblock: uniquely reactive Lys residues on cowpea mosaic virus. Chem Biol 11:855\u2013863. https:\/\/doi.org\/10.1016\/j.chembiol.2004.04.011","journal-title":"Chem Biol"}],"container-title":["Methods in Molecular Biology","Biomedical Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4402-7_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T12:46:17Z","timestamp":1741005977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4402-7_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071644010","9781071644027"],"references-count":35,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4402-7_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"4 March 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}